Angeles Wealth Management LLC acquired a new stake in CME Group Inc. (NASDAQ:CME – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 795 shares of the financial services provider’s stock, valued at approximately $219,000.
Several other institutional investors have also modified their holdings of the company. Nordea Investment Management AB lifted its holdings in shares of CME Group by 2.1% in the second quarter. Nordea Investment Management AB now owns 32,575 shares of the financial services provider’s stock valued at $8,899,000 after buying an additional 655 shares during the period. Aware Super Pty Ltd as trustee of Aware Super lifted its holdings in shares of CME Group by 424.3% in the second quarter. Aware Super Pty Ltd as trustee of Aware Super now owns 47,099 shares of the financial services provider’s stock valued at $12,981,000 after buying an additional 38,115 shares during the period. Turtle Creek Wealth Advisors LLC lifted its holdings in shares of CME Group by 2.7% in the second quarter. Turtle Creek Wealth Advisors LLC now owns 19,584 shares of the financial services provider’s stock valued at $5,398,000 after buying an additional 519 shares during the period. Rosenberg Matthew Hamilton lifted its holdings in shares of CME Group by 11.9% in the second quarter. Rosenberg Matthew Hamilton now owns 716 shares of the financial services provider’s stock valued at $197,000 after buying an additional 76 shares during the period. Finally, Generali Asset Management SPA SGR lifted its holdings in shares of CME Group by 91.7% in the second quarter. Generali Asset Management SPA SGR now owns 7,550 shares of the financial services provider’s stock valued at $2,081,000 after buying an additional 3,612 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group Stock Up 2.1%
Shares of CME Group stock opened at $267.93 on Friday. The stock has a 50-day moving average price of $267.30 and a 200 day moving average price of $271.38. The company has a market cap of $96.56 billion, a P/E ratio of 25.94, a P/E/G ratio of 6.16 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio is currently 48.40%.
Insider Transactions at CME Group
In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This represents a 40.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the transaction, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Several equities research analysts have recently commented on the company. TD Cowen upped their target price on CME Group from $281.00 to $288.00 and gave the company a “hold” rating in a report on Wednesday, October 8th. UBS Group reduced their target price on CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a report on Monday, September 8th. Deutsche Bank Aktiengesellschaft reduced their target price on CME Group from $276.00 to $266.00 and set a “hold” rating for the company in a report on Thursday, October 9th. Morgan Stanley upped their target price on CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a report on Wednesday, October 1st. Finally, Oppenheimer upped their target price on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a report on Thursday, July 24th. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $283.71.
View Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Ride Out The Recession With These Dividend Kings
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- 3 Fintech Stocks With Good 2021 Prospects
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- 3 Best Fintech Stocks for a Portfolio Boost
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.